Kaplan-Meier analysis demonstrated that breast cancer patients with high CYP1B1 expression had decreased probability of overall survival (Figure 3A) and disease-free survival (Figure 3B) than those with low CYP1B1 expression. Here, CYP1B1 is linked to breast cancer.